Original Research
Published on 07 May 2026
Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label, phase 2 trial (HCHTOG1906)
in Cancer Immunity and Immunotherapy
- 202 views